Merit Medical Systems awarded Lewis Sheri 8,371 shares at $0 per share, leaving the executive with 8,371 shares after the transaction. The award represents 100.0% of his resulting Merit Medical shareholding, giving investors a precise view of the ownership position tied to this transaction.
Key Highlights
- Lewis Sheri held 8,371 Merit Medical shares after the transaction.
- The award was recorded on September 4, 2026, under transaction code A.
- The transaction represented about 100.0% of Sheri’s resulting shareholding.
MERIT MEDICAL SYSTEMS INC (NASDAQ: MMSI) awarded Lewis Sheri 8,371 shares at $0 per share. Sheri is the company’s executive vice president of Global Operations.
Share Award Recorded at Zero Cost
Lewis Sheri held 8,371 shares of Merit Medical Systems after the transaction. The award was recorded at $0 per share.
Award Equals Entire Resulting Holding
The 8,371-share award represented about 100.0% of Lewis Sheri’s resulting shareholding in Merit Medical Systems. That percentage describes the transaction relative to the shares he held after it.
FAQs
Q: How many Merit Medical shares did Lewis Sheri receive?
A: Lewis Sheri received 8,371 Merit Medical Systems shares at $0 per share. He held 8,371 shares after the award was completed.
Q: What does the MMSI share award mean for investors?
A: The award represented about 100.0% of Lewis Sheri’s resulting shareholding in Merit Medical Systems. He held 8,371 shares after the transaction, and the award was recorded at $0 per share.
Q: When did Merit Medical record Lewis Sheri’s share award?
A: Merit Medical Systems recorded the award on September 4, 2026. The transaction used code A and involved 8,371 shares at $0 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.